SCHEMBL11299959

SCHEMBL11299959

COC(=O)c1ccc(N(c2cccc3cccnc23)C2CCNC2=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.44
▸ HTT P42858 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ EGLN1 Q9GZT9 1/20 0.41
▸ SLC40A1 Q9NP59 3/20 0.39
▸ MAPT P10636 5/20 0.37
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ GAA P10253 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ LMNA P02545 5/20 0.36
▸ METAP2 P50579 1/20 0.36
▸ METAP1 P53582 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ KAT2B Q92831 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TNKS O95271 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301410 0.87 HDAC6 (0.47) L3MBTL1GAAHDAC6TNKSTNKS2
SCHEMBL11301393 0.83 ALOX15 (0.56) ALDH1A1HTTALOX15MAPTGAA
SCHEMBL11296506 0.80 ALOX15 (0.44) ALDH1A1HTTALOX15L3MBTL1KDM4E
SCHEMBL11296058 0.80 MEN1 (0.47) ALDH1A1HTTMAPTL3MBTL1GAA
SCHEMBL11299441 0.77 MAPK14 (0.37) MAPTL3MBTL1GAAKDM4EMEN1
SCHEMBL11295039 0.77 PSEN1 (0.40) GAAKMT2ALMNASMN1; SMN2TSHR
SCHEMBL28283538 0.76 ALDH1A1 (0.54) ALDH1A1HTTALOX15EGLN1SLC40A1
SCHEMBL11296615 0.75 FLT1 (0.38) MAPTMEN1KMT2A
SCHEMBL11304990 0.72 HDAC6 (0.48) ALDH1A1L3MBTL1MEN1KMT2AHDAC6
SCHEMBL11301790 0.67 HDAC6 (0.36) ALOX15KDM4EMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback